Custom Search
Sumatriptan News
Spectrum Pharmaceuticals, Inc. announced that it has filed its thirteenth Abbreviated New Drug Application (ANDA), which is for an injectable drug, with the U.S. Food and Drug Administration (FDA)
Spectrum Pharmaceuticals currently has nine other ANDAs that are under review at the FDA, including an ANDA with Paragraph IV certification for sumatriptan succinate injection, the generic form of GlaxoSmithKline's Imitrex(R)...
Acute Multiple Migraine Benefits From Single Tablet Containing Sumatriptan Succinate And Naproxen Sodium
New data from several clinical studies presented at the 58th Annual Meeting of the American Academy of Neurology (AAN) describe multiple benefits of a single tablet containing sumatriptan succinate and naproxen sodium for the...
Caretek Medical Announces Lead Drug Candidate For ImplaJect® Development
Caretek Medical Ltd, an Oxford-based company developing an innovative needle-free drug delivery system known as ImplaJect®, today announced the selection of Sumatriptan Succinate as its lead drug compound at the Needle-Free and...